Catalyst Wire Dossier Catalyst Wire Dossier

Tor Kinase Inhibitor

· AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tor Kinase Inhibitor, covering 2012-07-10 to 2012-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Tor Kinase Inhibitor in Advanced Tumors [Phase 1]

See pricing